From: purdue.edu Accurately diagnosing the spread of cancer often involves painful and invasive biopsy procedures. The use of a “liquid biopsy,” which involves a simple blood draw, has been shown in a five-year clinical trial to accurately detect and monitor certain kinds of breast cancer. The study involves circulating tumor DNA (ctDNA) and circulating tumor cells (CTC), genetic and cellular …